Your browser doesn't support javascript.
loading
Pretreatment Positron Emission Tomography with 18F-Fluorodeoxyglucose May Be a Useful New Predictor of Early Progressive Disease following Atezolizumab plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma.
Kawamura, Yusuke; Kobayashi, Masahiro; Shindoh, Junichi; Matsumura, Masaru; Okubo, Satoshi; Muraishi, Nozomu; Fujiyama, Shunichiro; Hosaka, Tetsuya; Saitoh, Satoshi; Sezaki, Hitomi; Akuta, Norio; Suzuki, Fumitaka; Suzuki, Yoshiyuki; Ikeda, Kenji; Arase, Yasuji; Hashimoto, Masaji; Kumada, Hiromitsu.
Afiliación
  • Kawamura Y; Department of Hepatology, Toranomon Hospital, Tokyo, Japan.
  • Kobayashi M; Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan.
  • Shindoh J; Department of Hepatology, Toranomon Hospital, Tokyo, Japan.
  • Matsumura M; Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan.
  • Okubo S; Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan.
  • Muraishi N; Hepatobiliary-pancreatic Surgery Division, Department of Gastroenterological Surgery, Toranomon Hospital, Tokyo, Japan.
  • Fujiyama S; Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan.
  • Hosaka T; Hepatobiliary-pancreatic Surgery Division, Department of Gastroenterological Surgery, Toranomon Hospital, Tokyo, Japan.
  • Saitoh S; Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan.
  • Sezaki H; Hepatobiliary-pancreatic Surgery Division, Department of Gastroenterological Surgery, Toranomon Hospital, Tokyo, Japan.
  • Akuta N; Department of Hepatology, Toranomon Hospital, Tokyo, Japan.
  • Suzuki F; Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan.
  • Suzuki Y; Department of Hepatology, Toranomon Hospital, Tokyo, Japan.
  • Ikeda K; Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan.
  • Arase Y; Department of Hepatology, Toranomon Hospital, Tokyo, Japan.
  • Hashimoto M; Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan.
  • Kumada H; Department of Hepatology, Toranomon Hospital, Tokyo, Japan.
Oncology ; 100(6): 320-330, 2022.
Article en En | MEDLINE | ID: mdl-35231914
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Oncology Año: 2022 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Oncology Año: 2022 Tipo del documento: Article País de afiliación: Japón